Literature DB >> 12153492

Homologous regulation of the heptahelical D1A receptor responsiveness: specific cytoplasmic tail regions mediate dopamine-induced phosphorylation, desensitization and endocytosis.

Adele Jackson1, Rafal M Iwasiow, Ziad Y Chaar, Marie-France Nantel, Mario Tiberi.   

Abstract

In the present study, we investigate the role of specific cytoplasmic tail (CT) regions of the D1A receptor in mediating dopamine (DA)-induced phosphorylation, desensitization and endocytosis. Results obtained in human embryonic kidney (HEK) cells expressing the wild-type (WT) or truncation forms (Delta425, Delta379 and Delta351) of the D1A receptor show that sequences located downstream of Gly379 regulate DA-mediated phosphorylation-dependent desensitization of D1A receptors. However, the longer truncation mutant Delta351 failed to undergo detectable DA-induced phosphorylation while exhibiting DA-induced desensitization features similar to the shorter truncation mutant Delta379. These data potentially suggest a novel role for a receptor phosphorylation-independent process in the DA-promoted D1A subtype desensitization. Our immunofluorescence data also suggest that sequences located between Cys351 and Gly379 play an important role in DA-mediated receptor endocytosis. Additionally, time-course studies were done in intact cells expressing WT or truncation receptors to measure the observed rate constant for adenylyl cyclase (AC) activation or k(obs), a parameter linked to the receptor-G protein coupling status. In agreement with the desensitization data, Delta425- and Delta379-expressing cells exhibit an increase of kobs in comparison with WT-expressing cells. Nevertheless, Delta351-expressing cells, which harbor similar desensitization features of Delta379-expressing cells, display no change in k(obs) when compared with WT-expressing cells. Our results suggest that a defective DA-induced endocytosis may hamper Delta351 resensitization and concomitant increase in k(obs). Thus, our study showing that specific D1A receptor CT sequences regulate DA-induced phosphorylation, desensitization, and endocytosis highlights the underlying molecular complexity of signaling at dopaminergic synapses.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12153492     DOI: 10.1046/j.1471-4159.2002.01001.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  6 in total

1.  The role of endocytosis in renal dopamine D1 receptor signaling.

Authors:  Hjalmar Brismar; Xiang Hua; Shinsuke Adachi; Ulla Holtbäck
Journal:  Pflugers Arch       Date:  2005-10-11       Impact factor: 3.657

2.  Endocytosis promotes rapid dopaminergic signaling.

Authors:  Sarah J Kotowski; F Woodward Hopf; Taban Seif; Antonello Bonci; Mark von Zastrow
Journal:  Neuron       Date:  2011-07-28       Impact factor: 17.173

3.  Dopamine D1-D2 receptor Heteromer-mediated calcium release is desensitized by D1 receptor occupancy with or without signal activation: dual functional regulation by G protein-coupled receptor kinase 2.

Authors:  Vaneeta Verma; Ahmed Hasbi; Brian F O'Dowd; Susan R George
Journal:  J Biol Chem       Date:  2010-08-31       Impact factor: 5.157

4.  The role of phosphorylation in D1 dopamine receptor desensitization: evidence for a novel mechanism of arrestin association.

Authors:  Ok-Jin Kim; Benjamin R Gardner; Daniel B Williams; Paul S Marinec; David M Cabrera; Jennifer D Peters; Chun C Mak; Kyeong-Man Kim; David R Sibley
Journal:  J Biol Chem       Date:  2003-12-04       Impact factor: 5.157

5.  Novel role of sorting nexin 5 in renal D(1) dopamine receptor trafficking and function: implications for hypertension.

Authors:  Van Anthony M Villar; Ines Armando; Hironobu Sanada; Lauren C Frazer; Christen M Russo; Patricia M Notario; Hewang Lee; Lauren Comisky; Holly Ann Russell; Yu Yang; Julie A Jurgens; Pedro A Jose; John E Jones
Journal:  FASEB J       Date:  2012-11-29       Impact factor: 5.191

Review 6.  The emerging role of sorting nexins in cardiovascular diseases.

Authors:  Jian Yang; Van Anthony M Villar; Selim Rozyyev; Pedro A Jose; Chunyu Zeng
Journal:  Clin Sci (Lond)       Date:  2019-03-15       Impact factor: 6.124

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.